Sign in
Taking people in United StatesNo phase

Studying how fat tissue responds to extra calories in adults with overweight or obesity

Tests how fat tissue grows during short-term overeating in adults with obesity or metabolic syndrome.

Key facts

Who runs it
Pennington Biomedical Research Center
Where
Baton Rouge, United StatesSee the site
Trial code
Registry title
Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
Status
Recruiting
People taking part
58 people, planned
Started
15 Sept 2020
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Control
  • Overfeeding
Record updated
8 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for men and pre-menopausal women aged 18-42 with a BMI of 23-35 kg/m2. They must agree to be randomized to a control group or an overfeeding group, and to drink deuterium-labeled water for 8 weeks.

Age
18-42 years
Sex
Men and pre-menopausal women
Earlier treatment
No unstable weight in the last 3 months (about 5% weight change or more). No previous bariatric or other obesity surgery.

Main reasons for not taking part

  • Type 1 or type 2 diabetes, or fasting blood glucose above 110 mg/dL (6.1 mmol/L)
  • Average blood pressure above 140/90 mmHg
  • Major organ disease, such as heart, kidney, lung, thyroid or liver disease
  • Pregnancy, breastfeeding, or a planned pregnancy in the next 6 months
  • Cancer in the last 5 years (some skin cancers are acceptable)

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Men and pre-menopausal women
  • 18-42 years of age
  • BMI 23-35 kg/m2 (± 0.5 will be accepted)
  • Are willing to drink deuterium-labeled water (2H2O) for 8 weeks
  • Are willing to be randomized to either a CTL or 30% OF group
  • For women, if not using pharmaceutical (hormonal) contraception (i.e. birth control pills, vaginal ring, injections, or implant), must agree to use either a double barrier method as a form of birth control to prevent pregnancy (i.e. male condom with spermicide, with or without cervical cap or diaphragm); use implants or intrauterine contraceptive devices; have a tubal ligation (surgically sterile); practice abstinence; or be in an established relationship with a vasectomized or same sex partner during the entire duration of the study
  • Must be willing to adhere to all study procedures, including attendance at all study visits
  • If enrolled, agree to maintain the same level of physical activity throughout the duration of the study
  • Must be willing to have blood stored for future research

Who cannot take part

  • Any current or previous eating disorders
  • Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulating agents, beta-blockers, antipsychotic medications, thiazolidinediones and other medications that may cause clinically significant weight gain or loss)
  • Chronic use of prescription weight loss medications or over the counter weight loss medications which, in the opinion of the MI, will impact the study
  • Chronic use of anti-depressant medications for less than 3 months
  • Previous bariatric or other surgeries for obesity
  • Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease) or abnormal liver enzymes that are, in the opinion of the MI, clinically significant and represent a problem for study inclusion
  • Self-reported positive test for human immunodeficiency virus, hepatitis B or hepatitis C
  • Had cancer in the last 5 years (some skin cancers acceptable)
  • Diagnosed psychotic conditions
  • Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL
  • Unstable weight in the last 3 months (± ~5% weight change)
  • Average screening blood pressure > 140/90 mmHg
  • Chronic smokers or users of tobacco products who cannot abstain for the duration of the inpatient visits
  • Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months
  • Partial or full hysterectomy
  • PCOS

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 42 years old?

Where in United States

  • Pennington Biomedical Research CenterBaton Rouge, United StatesContact: Ursula White, Ph.D.Taking people

About the trial

What the trial wants to find out

Adipose, or fat, tissue is a plastic organ that retains the ability to expand and store excess calories during positive energy balance in humans. The capacity of subcutaneous (subQ) adipose tissue to expand and remodel is an important determinant of obesity-related health complications, and impaired expansion of subQ fat tissue is thought to contribute to the risk of diseases such as the Metabolic Syndrome (MetS) and type 2 diabetes mellitus (T2D). The objectives of the study are to evaluate the changes and mechanisms of (subQ) adipose tissue expandability that occur as a result of short-term weight gain and to investigate the effects on cardio-metabolic health outcomes. Findings from this study will provide new insight into the dynamics of adipose expansion and remodeling during changes in energy balance and how this may impact future fat tissue function and metabolic health.

The 2 groups in the trial

  • ControlTreatment being tested

    The control group will be expected to maintain their weight within 1 kg of baseline weight throughout the duration of the study.

  • OverfeedingTreatment being tested

    The overfeeding group will be subjected to a similar relative change in energy intake, in which their dietary intake will be 30% more kcal/d than needed for weight maintenance.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
Plain-language title
Studying how fat tissue responds to extra calories in adults with overweight or obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04583514, who can take part
Record updated
8 April 2026